Literature DB >> 25244569

Toward synthetic biology with engineered T cells: a long journey just begun.

Carl H June1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25244569      PMCID： PMC4174426          DOI： 10.1089/hum.2014.2533

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  66 in total

1.  Extensive replicative capacity of human central memory T cells.

Authors:  Marcela V Maus; Birgit Kovacs; William W Kwok; Gerald T Nepom; Katia Schlienger; James L Riley; David Allman; Terri H Finkel; Carl H June
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

Review 2.  Antibody-modified T cells: CARs take the front seat for hematologic malignancies.

Authors:  Marcela V Maus; Stephan A Grupp; David L Porter; Carl H June
Journal:  Blood       Date:  2014-02-27       Impact factor: 22.113

Review 3.  Cross-contamination of cells in culture.

Authors:  W A Nelson-Rees; D W Daniels; R R Flandermeyer
Journal:  Science       Date:  1981-04-24       Impact factor: 47.728

4.  Improved detection of immune complexes in human and mouse serum using a microassay adaptation of the C1Q binding test.

Authors:  C H June; C E Contreras; L H Perrin; P Lambert
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

5.  A theory of self-nonself discrimination.

Authors:  P Bretscher; M Cohn
Journal:  Science       Date:  1970-09-11       Impact factor: 47.728

6.  Circulating and tissue-bound immune complex formation in murine malaria.

Authors:  C H June; C E Contreras; L H Perrin; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

7.  Gene therapy for human genetic disease?

Authors:  T Friedmann; R Roblin
Journal:  Science       Date:  1972-03-03       Impact factor: 47.728

8.  Association between cyclosporin neurotoxicity and hypomagnesaemia.

Authors:  C B Thompson; C H June; K M Sullivan; E D Thomas
Journal:  Lancet       Date:  1984-11-17       Impact factor: 79.321

9.  Immune reconstitution following autologous transfers of CD3/CD28 stimulated CD4(+) T cells to HIV-infected persons.

Authors:  Wendy B Bernstein; Josephine H Cox; Naomi E Aronson; LaRee Tracy; Katia Schlienger; Silvia Ratto-Kim; Robin Garner; Julio Cotte; Zhaohui Zheng; Lena Winestone; Caroline Liebig; Lynee M Galley; Mark Connors; Deborah L Birx; Richard G Carroll; Bruce L Levine
Journal:  Clin Immunol       Date:  2004-06       Impact factor: 3.969

10.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

Authors:  Pablo Tebas; David Stein; Winson W Tang; Ian Frank; Shelley Q Wang; Gary Lee; S Kaye Spratt; Richard T Surosky; Martin A Giedlin; Geoff Nichol; Michael C Holmes; Philip D Gregory; Dale G Ando; Michael Kalos; Ronald G Collman; Gwendolyn Binder-Scholl; Gabriela Plesa; Wei-Ting Hwang; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2014-03-06       Impact factor: 91.245
View more
  3 in total

Review 1.  Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir.

Authors:  James L Riley; Luis J Montaner
Journal:  J Infect Dis       Date:  2017-03-15       Impact factor: 5.226

Review 2.  CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV.

Authors:  Gloria B Kim; Kristen Hege; James L Riley
Journal:  Front Immunol       Date:  2019-09-27       Impact factor: 7.561

Review 3.  DCision-making in tumors governs T cell anti-tumor immunity.

Authors:  Francesca Alfei; Ping-Chih Ho; Wan-Lin Lo
Journal:  Oncogene       Date:  2021-07-21       Impact factor: 9.867
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.